JP6641297B2 - 発光源基質を安定させる組成物及び方法 - Google Patents
発光源基質を安定させる組成物及び方法 Download PDFInfo
- Publication number
- JP6641297B2 JP6641297B2 JP2016569444A JP2016569444A JP6641297B2 JP 6641297 B2 JP6641297 B2 JP 6641297B2 JP 2016569444 A JP2016569444 A JP 2016569444A JP 2016569444 A JP2016569444 A JP 2016569444A JP 6641297 B2 JP6641297 B2 JP 6641297B2
- Authority
- JP
- Japan
- Prior art keywords
- tak
- alkyl
- att
- triazin
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Electroluminescent Light Sources (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462002363P | 2014-05-23 | 2014-05-23 | |
| US62/002,363 | 2014-05-23 | ||
| PCT/US2015/032439 WO2015179864A1 (en) | 2014-05-23 | 2015-05-26 | Compositions and methods for stabilizing luminogenic substrates |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017519977A JP2017519977A (ja) | 2017-07-20 |
| JP2017519977A5 JP2017519977A5 (enExample) | 2018-06-21 |
| JP6641297B2 true JP6641297B2 (ja) | 2020-02-05 |
Family
ID=53434457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016569444A Active JP6641297B2 (ja) | 2014-05-23 | 2015-05-26 | 発光源基質を安定させる組成物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9676997B2 (enExample) |
| EP (1) | EP3146066B1 (enExample) |
| JP (1) | JP6641297B2 (enExample) |
| KR (1) | KR102456212B1 (enExample) |
| CN (1) | CN106661028B (enExample) |
| AU (1) | AU2015263901B2 (enExample) |
| BR (1) | BR112016027504B1 (enExample) |
| CA (1) | CA2949447C (enExample) |
| SG (1) | SG11201609382WA (enExample) |
| WO (1) | WO2015179864A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019028272A1 (en) * | 2017-08-04 | 2019-02-07 | Promega Corporation | COMPOSITIONS AND METHODS FOR STABILIZING LUCIFERIN BENZOTHIAZOLE ANALOGS |
| KR20250029277A (ko) | 2018-10-03 | 2025-03-04 | 프로메가 코포레이션 | 코엘렌테라진 및 이의 유사체 및 유도체를 안정화하기 위한 조성물 및 방법 |
| CN111116594B (zh) * | 2019-12-03 | 2021-05-28 | 山东大学 | 一种C-6位改造NanoLuc类型类似物及其制备方法与应用 |
| WO2025242077A1 (zh) * | 2024-05-21 | 2025-11-27 | 深圳琅技生命科技有限公司 | 用于稳定腔肠素及其类似物的组合物及方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2000622A1 (de) * | 1970-01-08 | 1971-07-22 | Agfa Gevaert Ag | Verfahren zur Stabilisierung von Silberbildern |
| JP4639904B2 (ja) * | 2005-03-30 | 2011-02-23 | チッソ株式会社 | 蛍光活性を有するルシフェラーゼの活性増強方法 |
| JP4761150B2 (ja) * | 2006-07-24 | 2011-08-31 | 独立行政法人産業技術総合研究所 | ハイスループット発光活性測定のためのセレンテラジン(ウミシイタケルシフェリン)溶液の安定化組成物および安定化法 |
| US7718389B2 (en) * | 2006-07-24 | 2010-05-18 | National Institute Of Advanced Industrial Science And Technology | Stabilizing composition and stabilizing method of coelenterazine solution for high-throughput measurement of luciferase activity |
| JP5774471B2 (ja) * | 2008-03-27 | 2015-09-09 | プロメガ コーポレイションPromega Corporation | シアノベンゾチアゾールコンジュゲートによるタンパク質標識 |
| BR112013010855A2 (pt) | 2010-11-02 | 2017-06-27 | Promega Corp | luciferases derivadas de oplophorus, novos substratos de coelenterazina e métodos de uso |
-
2015
- 2015-05-26 KR KR1020167033229A patent/KR102456212B1/ko active Active
- 2015-05-26 CA CA2949447A patent/CA2949447C/en active Active
- 2015-05-26 BR BR112016027504-7A patent/BR112016027504B1/pt active IP Right Grant
- 2015-05-26 US US14/721,727 patent/US9676997B2/en active Active
- 2015-05-26 CN CN201580026864.3A patent/CN106661028B/zh active Active
- 2015-05-26 EP EP15730321.5A patent/EP3146066B1/en active Active
- 2015-05-26 WO PCT/US2015/032439 patent/WO2015179864A1/en not_active Ceased
- 2015-05-26 SG SG11201609382WA patent/SG11201609382WA/en unknown
- 2015-05-26 AU AU2015263901A patent/AU2015263901B2/en active Active
- 2015-05-26 JP JP2016569444A patent/JP6641297B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015179864A1 (en) | 2015-11-26 |
| AU2015263901A1 (en) | 2016-11-24 |
| KR102456212B1 (ko) | 2022-10-20 |
| CN106661028B (zh) | 2021-08-06 |
| SG11201609382WA (en) | 2016-12-29 |
| US20150337198A1 (en) | 2015-11-26 |
| AU2015263901B2 (en) | 2021-03-11 |
| EP3146066A1 (en) | 2017-03-29 |
| CN106661028A (zh) | 2017-05-10 |
| CA2949447A1 (en) | 2015-11-26 |
| EP3146066B1 (en) | 2018-03-14 |
| BR112016027504B1 (pt) | 2023-04-18 |
| CA2949447C (en) | 2022-10-04 |
| KR20170012271A (ko) | 2017-02-02 |
| JP2017519977A (ja) | 2017-07-20 |
| BR112016027504A2 (enExample) | 2017-08-15 |
| US9676997B2 (en) | 2017-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6641297B2 (ja) | 発光源基質を安定させる組成物及び方法 | |
| Churakov et al. | Progress in 1, 2, 3, 4-Tetrazine Chemistry | |
| Zhou et al. | Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quindoline derivatives, in human cancer cell lines | |
| Nguyen et al. | Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)–Tyrosyl-DNA Phosphodiesterase I (TDP1) inhibitors | |
| Trivedi et al. | Synthesis and anti-tubercular evaluation of some novel pyrazolo [3, 4-d] pyrimidine derivatives | |
| Zhou et al. | Characterization of the fluorescence properties of 4‐dialkylaminochalcones and investigation of the cytotoxic mechanism of chalcones | |
| Saber et al. | A facile method for preparation and evaluation of the antimicrobial efficiency of various heterocycles containing thieno [2, 3-d] pyrimidine | |
| Stasevych et al. | Synthesis and investigation of antimicrobial and antioxidant activity of anthraquinonylhydrazones | |
| Le Roux et al. | Preparation and optimization of pyrazolo [1, 5-a] pyrimidines as new potent PDE4 inhibitors | |
| Hassaneen et al. | Synthesis, reactions, and antimicrobial activity of some novel pyrazolo [3, 4‐d] pyrimidine, pyrazolo [4, 3‐e][1, 2, 4] triazolo [1, 5‐c] pyrimidine, and pyrazolo [4, 3‐e][1, 2, 4] triazolo [3, 4‐c] pyrimidine derivatives | |
| Shukla et al. | Pyrrole-pyridine chelating motif on the β-carboline skeleton: Selective Zn2+ sensing via inhibition of ESIPT | |
| Pinson et al. | Synthesis and pharmacological evaluation of 4-iminothiazolidinones for inhibition of PI3 kinase | |
| US7332354B2 (en) | Compounds for chemiluminescense procedures | |
| Rudenko et al. | Reactions of N‐arylmaleimides with 3‐amino‐1, 2, 4‐triazole and 2‐aminobenzimidazole | |
| EP3661932B1 (en) | Compositions and methods for stabilizing benzothiazole luciferin analogs | |
| JP6932082B2 (ja) | ルシフェリンの安定化方法及び生物発光の測定方法 | |
| Litvinchuk et al. | An efficient approach to the synthesis of 7-thioxosubstituted [1, 3] thiazolo [3, 2-c] pyrimidines and evaluation of their antimicrobial and antioxidant activities | |
| Cigáň et al. | Fluorescence of isatin N‐phenylsemicarbazones: aggregation and hydrazide–hydrazonol tautomerism | |
| Shindy et al. | Effects of chemical structure, solvent and solution pH on the visible spectra of some new methine cyanine dyes | |
| Khodabakhshi et al. | PTSA‐Catalyzed Cyclization of 6‐Aminouracils with Diimines: Efficient Synthesis of Functionalized Tetrahydropyrimido [4, 5‐d] pyrimidine‐2, 4‐diones | |
| Andrade et al. | Self-association of free base porphyrins with aminoacid substituents in AOT reverse micelles | |
| Parmar et al. | Room‐Temperature Accessible Stereospecific Synthesis of Methyl‐(Z)‐2‐(7‐methyl‐3‐oxo‐5H‐thiazolo [3, 2‐a] pyrimidin‐2 (3H)‐ylidene) acetates: Cd2+ Fluorescence Probe and DU145 Cell Study | |
| Biradar et al. | A mini library of novel triazolothiadiazepinylindole analogues: Synthesis, antioxidant and antimicrobial evaluations | |
| Umoh et al. | Potentials of N-(2, 4-dinitro-1-naphthyl)-p-toluenesulphonamide and 2, 4-dinitro-1-naphthol as novel charge transfer acceptors in pharmaceutical analysis of some quinolones and cephalosporins | |
| CN117597125A (zh) | 吲哚取代的喹啉类化合物及其与plk1抑制剂联合治疗癌症 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180511 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180511 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190509 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190806 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20191205 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20191227 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6641297 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |